|[October 31, 2013]
Research and Markets: MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/h9xcnc/medipoint)
has announced the addition of the "MediPoint:
Drug-Eluting Balloons - US Analysis and Market Forecasts"
report to their offering.
The report provides in-depth insight into the use of DEB for coronary
and peripheral applications in the lower extremity including in-stent
restenosis, bifurcation lesions, small vessel disease, femoropopliteal
artery and below-the-knee lesions, chronic total occlusions, acute
myocardial infarction and lesions in diabetics.
The DEB market in the US was assessed to identify the unmet needs in the
market, understand the regulatory challenges DEB manufacturers will
encounter in the US, identify the challenges to adoption in clinical
practice and evaluate future adoption of DEB for select coronary and
peripheral indications. The US sales expectations are discussed through
careful analysis of adoption patterns of using DEB.
Clients can use this report to better understand the scope of this
technology and for strategic planning to explore opportunities in this
dynamic market. The report provides insights into the competitive
landscape, the marketed and pipeline DEB products, the current and
emerging players and comparative market analysis of different types of
interventional techniques used to treat coronary and peripheral artery
disease. This report is built using data and information sourced from
secndary sources and primary research interviews and survey with
leading Interventional Cardiologists and Interventional Radiologists,
with in-house analysis conducted by a team of industry experts.
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies
through a review of pipeline products and technologies, and by
identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends that will
shape and drive the DEB market in the US.
- Drive revenues by understanding the key trends, innovative products
and technologies, market segments, and companies likely to impact the US
DEB market in the future.
- Formulate effective sales and marketing strategies by understanding
the competitive landscape and by analyzing the performance of various
- Identify emerging players with potentially strong product portfolios
and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the US DEB market by disease and indication from
- Organize your sales and marketing efforts by identifying the market
categories and segments that present maximum opportunities for
consolidations, investments and strategic partnerships.
Key Topics Covered
1 List of Tables
3 Disease Overview
4 Competitive Assessment
5 Unmet Needs
6 Pipeline Products
7 Clinical Trial Analysis
8 Industry Overview
9 Current and Future Players
10 Market Drivers, Opportunities, Barriers and Substitutes
11 Drug-Eluting Balloon Market Analysis
12 Country Outlooks & Forecasts
Boston Scientific Corporation
Concept Medical Research
DSM (News - Alert) Biomedical
Elixir Medical Corporation
LifeTech Scientific Corporation
Vascular Nanotransfer Technologies
For more information visit http://www.researchandmarkets.com/research/h9xcnc/medipoint
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]